NCT03358329View on ClinicalTrials.gov

Safety Evaluation of Repeat Placement of the S8 Sinus Implant in Chronic Sinusitis Patients With Nasal Polyps (ENCORE)

PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 13, 2017

Primary Completion Date

January 17, 2019

Study Completion Date

January 17, 2019

Conditions
Chronic SinusitisNasal Polyposis
Interventions
COMBINATION_PRODUCT

S8 Sinus Implant

In-office bilateral placement of the S8 Sinus Implant (mometasone furoate, 1350 mcg) in the ethmoid sinuses

Trial Locations (9)

10016

Madison ENT, New York

29025

Charlotte Eye, Ear, Nose and Throat Associates, Concord

40207

Advanced ENT & Allergy, Louisville

60540

DuPage Medical Group, Naperville

70433

Associated Surgical Specialists, Covington

84341

Bridgerland Clinical Research, North Logan

87109

BreatheAmerica of Albuquerque, Albuquerque

95815

Sacramento ENT, Sacramento

06519

Yale University School of Medicine, New Haven

Sponsors

Lead Sponsor

Intersect ENT
All Listed Sponsors
lead

Intersect ENT

INDUSTRY

NCT03358329 - Safety Evaluation of Repeat Placement of the S8 Sinus Implant in Chronic Sinusitis Patients With Nasal Polyps (ENCORE) | Biotech Hunter | Biotech Hunter